)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Dermapharm (DMP) investor relations material
Dermapharm Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
High-margin branded pharmaceuticals and international segments drove growth, with international up 10% and Alargo Pharma up 17% year-over-year as of September 2025, nearly offsetting declines in vaccine and parallel import businesses.
ARCO Pharma and Arkopharma are undergoing transformation, with a turnaround expected by H2 2026; new product launches, marketing strategies, and restructuring are underway.
Revenue for the first nine months of 2025 decreased by 2.3% year-over-year to €869.4 million, mainly due to restructuring in the Parallel import business and Arkopharma, partially offset by strong growth in Branded pharmaceuticals.
Adjusted EBITDA declined by 1.8% to €236.0 million, with the margin stable at 27.1%.
Net profit for the period was €95.2 million, up from €92.7 million in the prior year, with EPS rising to €1.77.
Financial highlights
Branded segment net sales grew 4% in Q3 2025 vs. Q3 2024, excluding vaccine business; branded pharmaceuticals revenue grew 4.2% to €449.8 million, with adjusted EBITDA up 1.2% to €199.6 million.
Q3 2025 revenue declined by 5.4% year-over-year to €294.9 million, while adjusted EBITDA increased by 0.8% to €88.1 million; EAT rose by 25.3% due to favorable interest rate SWAP valuation.
Gross margin improved by 4 percentage points year-over-year in Q3 2025, supported by cost-cutting measures and lower material costs.
Personnel expenses rose due to restructuring provisions of €2.1 million in Q3 and €5 million year-to-date.
Free cash flow for year-to-date September 2025 was €11 million lower than last year; cash conversion at 55%.
Outlook and guidance
Management confirms full-year 2025 guidance: revenues of €1,160–1,200 million and adjusted EBITDA of €322–332 million.
October performance was ahead of budget; November expected to be strong due to seasonality, especially in vitamin products.
Current trading is in line with budget, and the positive outlook for Q4 2025 supports the guidance.
ARCO Pharma: Key drivers for H2 2026 turnaround
AXI Corp: Sustain contribution margin gains?
What drives Q4 confidence despite YTD vaccine impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Dermapharm earnings date
Q4 202531 Mar, 2026
Next Dermapharm earnings date
Q4 202531 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Dermapharm Holding SE is a Germany-based pharmaceutical company specializing in the development, production, and marketing of branded prescription and over-the-counter (OTC) medicines, dietary supplements, and medical devices. The company focuses on niche markets, offering a diverse portfolio of products across therapeutic areas such as dermatology, allergy, and pain management. Dermapharm also provides contract manufacturing services to third-party pharmaceutical companies. The company is headquartered in Grünwald, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage